Vanderbilt Lung Institute at One Hundred Oaks — Nashville, Tennessee

Vanderbilt Lung Institute at One Hundred Oaks is a clinical research site located in Nashville, Tennessee, United States 37204.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Lung Institute at One Hundred Oaks has participated in 1 clinical trials.

Therapeutic areas: Idiopathic Pulmonary Fibrosis.

Sponsors: Pliant Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Lung Institute at One Hundred Oaks?

Vanderbilt Lung Institute at One Hundred Oaks has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Lung Institute at One Hundred Oaks conducted?

Vanderbilt Lung Institute at One Hundred Oaks has 1 clinical trials on record. Their work covers Idiopathic Pulmonary Fibrosis.

Is Vanderbilt Lung Institute at One Hundred Oaks accredited by Crixeo Health?

Vanderbilt Lung Institute at One Hundred Oaks has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Lung Institute at One Hundred Oaks?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.